This is a firm fixed price delivery order awarded by the Northeast Area of the federal agency to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The $15,078.24 contract is for a MiSeq silver support plan, which provides maintenance and technical support services for Illumina's MiSeq sequencing system. The award does not have a set-aside designation. Illumina has a history of providing a range of sequencing platforms, consumables, and bioinformatics products to...
This is a $111,420.00 firm fixed price purchase order awarded by the U.S. Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc. for a "SILVER SUPPORT PLAN" contract. The contract has a completion date of September 25, 2022 and does not utilize a set-aside designation. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis. Through past prime federal contract awards, Illumina has provided a range of goods and...
This is a firm-fixed-price purchase order contract awarded by the U.S. Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of one MiSeq System and a 12-month MiSeq Silver Support Plan, valued at $88,357.50. The contract was awarded on a sole-source basis under the authority of 10 U.S.C. 2304(c)(1), as the Naval Health Research Center requires Illumina's proprietary MiSeq technology for their...
This firm fixed price delivery order contract was awarded by the Southeast Area office of a civilian federal agency to Illumina, Inc. for a MiSeQ Silver Support Plan, at a ceiling value of $20,500.27. The contract does not have a set-aside designation. Illumina is a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, and has previously provided sequencing systems, reagents, and services to support research and diagnostics across various government agencies....
The U.S. government has awarded a firm-fixed-price delivery order contract to Illumina, Inc., a manufacturer of sequencing and analysis solutions, for a MiSeq Silver Support Plan. The $14,562.64 contract, which has no set-aside designation, was awarded by the Midwest Area division of a civilian federal agency. The support plan is intended to provide maintenance and services for the MiSeq sequencing system used for laboratory equipment, consumables, and services. Illumina has previously...
This federal contract award was made by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $119,742.91 firm fixed price purchase order is for a MiSeq System, related reagents, and support services to be performed in San Diego, CA. The contract does not have a set-aside designation. The award was made on a sole source basis to Illumina, as the provider of the proprietary...
This is a $84,332.60 firm fixed price purchase order contract awarded by the Office of Acquisitions and Grants, a civilian agency, to Illumina, Inc. for a MiSeq Silver Support Plan. The contract has an ultimate completion date of August 14, 2026 and was awarded on August 15, 2020. This award does not have a set-aside designation. Illumina, a manufacturer of sequencing and array-based solutions, has previously received federal contracts and subcontracts from agencies like NIH, CDC, USDA, and VA...
This federal contract award is for a MiSeq Silver Support Plan from Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The $12,875 firm fixed price purchase order was issued by a civilian federal agency, with a performance location in Calverton, Maryland. The contract includes full coverage for parts, labor, and travel as well as reagent replacement upon hardware failures for the MiSeq sequencing system. Illumina has a history of providing sequencing products and...
This is a firm fixed price purchase order contract awarded by the Naval Sea Systems Command to Illumina, Inc. to provide a MiSeq DNA Sequencer for $111,782.23. The contract has no set-aside designation. Illumina is a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, and has previously provided various sequencing systems, reagents, and services to support research and diagnostics across multiple federal agencies. This award is likely part of Illumina's...
This is a firm fixed price purchase order awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Illumina, Inc., a manufacturer of genomic sequencing instrumentation and reagents. The $153,192.00 contract is for the provision of a MiSeq Silver sequencing system and associated products to support the agency's nucleic acid sequencing needs, specifically to characterize biological threats at the Naval Medical Research Center's Biological Defense Research...